SpyGlass Pharma, Inc. (SGP)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-06) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-14) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-26) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Audit Information | — |
|
| Statements | ||
| Balance Sheets | ||
| Balance Sheets (P) | ||
| Statements of Operations and Comprehensive Loss | ||
| Condensed Statements of Redeemable Convertible Preferred Stock and Stockholdersâ Equity (deficit) | — |
|
| Statements of Cash Flows | ||
| Statements of Redeemable Convertible Preferred Stock and Stockholders Deficit | — |
|
| Notes | ||
| Award Timing Disclosure | — |
|
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Defined Contribution Plan | ||
| Description of Business | ||
| Equity Based Compensation | ||
| Fair Value Measurements | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Net Loss Per Share | ||
| Property and Equipment | ||
| Property and Equipment, Net | — |
|
| Redeemable Convertible Preferred Stock and Stockholders Deficit | — |
|
| Redeemable Convertible Preferred Stock and Stockholdersâ Equity (deficit) | — |
|
| Related Party Transactions | ||
| Segment Information | ||
| Subsequent Events | — |
|
| Summary of Significant Accounting Policies | ||